BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5113829)

  • 21. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia.
    Nasrallah HA; Tandon R
    J Clin Psychiatry; 2002; 63 Suppl 13():12-20. PubMed ID: 12562142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alexithymia and schizophrenic psychopathology.
    Maggini C; Raballo A
    Acta Biomed; 2004 Apr; 75(1):40-9. PubMed ID: 15315086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU; Jeon YW; Lee HK; Jun TY
    Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial response to antipsychotic treatment: the patient with enduring symptoms.
    Emsley RA
    J Clin Psychiatry; 1999; 60 Suppl 23():10-3. PubMed ID: 10625194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Generic quetiapine in the treatment of acute schizophrenia and schizoaffective disorder].
    György B; Robert K; László C; Andrea J;
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):293-303. PubMed ID: 19419015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current clinical experience with clothiapine (Entumin)].
    Vencovský E; Peterová E; Baudis P
    Cesk Psychiatr; 1970 Apr; 66(2):93-7. PubMed ID: 5444522
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of quetiapine on aggression and hostility in patients with schizophrenia.
    Arango C; Bernardo M
    Hum Psychopharmacol; 2005 Jun; 20(4):237-41. PubMed ID: 15830402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Early phase II study of quetiapine fumarate on schizophrenia].
    Murasaki M; Yamauchi T; Yagi G; Nakajima T; Nakane Y; Kudo Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Apr; 19(2):53-66. PubMed ID: 10464776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Negative symptoms, depression, anxiety and alexithymia in DSM III-R schizophrenic patients].
    Nkam I; Langlois-Thery S; Dollfus S; Petit M
    Encephale; 1997; 23(4):267-72. PubMed ID: 9417392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication.
    Stefánsson SB; Jónsdóttir TJ
    Biol Psychiatry; 1996 Jul; 40(1):19-27. PubMed ID: 8780851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and tolerability of quetiapine in hospitalised schizophrenic patients during the acute treatment phase: a PMS study].
    Leweke FM; Gerth CW; Koethe D; Nolden BM; Klosterkötter J
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):211-9. PubMed ID: 17230308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased libido associated with quetiapine.
    Menon A; Williams RH; Watson S
    J Psychopharmacol; 2006 Jan; 20(1):125-7. PubMed ID: 16354735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disorders of premorbid social adaptation as a predictor of the 5-year prognosis of schizophrenic psychoses].
    Möller HJ; Scharl W; von Zerssen D
    Nervenarzt; 1984 Jul; 55(7):358-64. PubMed ID: 6472525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of the emotional blunting and its prognostic importance during neuroleptic treatment of schizophrenia].
    Kukulska D
    Psychiatr Pol; 2003; 37(6):999-1012. PubMed ID: 14727372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influences of cylert upon memory changes with ECT.
    Small IF; Sharpley P; Small JG
    Am J Psychiatry; 1968 Dec; 125(6):837-40. PubMed ID: 4386991
    [No Abstract]   [Full Text] [Related]  

  • 37. [Evaluation of the therapeutic spectrum of entumine-chloro-2-11-dibenzothiazepine. A study based on 50 clinical cases].
    Haker O; Nassi G; Cohn D
    Encephale; 1972; 61(6):550-9. PubMed ID: 4664637
    [No Abstract]   [Full Text] [Related]  

  • 38. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
    Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
    Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mental health research at a state hospital. An attempt at a balanced program.
    Rappaport M
    Ment Hyg; 1968 Jan; 52(1):110-23. PubMed ID: 4229896
    [No Abstract]   [Full Text] [Related]  

  • 40. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
    Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
    Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.